EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 22021D1508
Decision of the EEA Joint Committee No 241/2018 of 5 December 2018 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2021/1508]
Decision of the EEA Joint Committee No 241/2018 of 5 December 2018 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2021/1508]
Decision of the EEA Joint Committee No 241/2018 of 5 December 2018 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2021/1508]
C/2018/8337
OJ L 337, 23.9.2021, p. 33–34
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
Date of entry into force unknown (pending notification) or not yet in force.
|
23.9.2021 |
EN |
Official Journal of the European Union |
L 337/33 |
DECISION OF THE EEA JOINT COMMITTEE No 241/2018
of 5 December 2018
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2021/1508]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,
Whereas:
|
(1) |
Commission Implementing Regulation (EU) 2018/1129 of 13 August 2018 approving acetamiprid as an existing active substance for use in biocidal products of product-type 18 (1) is to be incorporated into the EEA Agreement. |
|
(2) |
Commission Implementing Regulation (EU) 2018/1130 of 13 August 2018 approving cypermethrin as an existing active substance for use in biocidal products of product-type 18 (2) is to be incorporated into the EEA Agreement. |
|
(3) |
Commission Implementing Regulation (EU) 2018/1131 of 13 August 2018 approving penflufen as an active substance for use in biocidal products of product-type 8 (3) is to be incorporated into the EEA Agreement. |
|
(4) |
Annex II to the EEA Agreement should therefore be amended accordingly, |
HAS ADOPTED THIS DECISION:
Article 1
The following points are inserted after point 12zzzzzl (Commission Implementing Decision (EU) 2018/619) of Chapter XV of Annex II to the EEA Agreement:
|
‘12zzzzzm. |
32018 R 1129: Commission Implementing Regulation (EU) 2018/1129 of 13 August 2018 approving acetamiprid as an existing active substance for use in biocidal products of product-type 18 (OJ L 205, 14.8.2018, p. 4). |
|
12zzzzzn. |
32018 R 1130: Commission Implementing Regulation (EU) 2018/1130 of 13 August 2018 approving cypermethrin as an existing active substance for use in biocidal products of product-type 18 (OJ L 205, 14.8.2018, p. 8). |
|
12zzzzzo. |
32018 R 1131: Commission Implementing Regulation (EU) 2018/1131 of 13 August 2018 approving penflufen as an active substance for use in biocidal products of product-type 8 (OJ L 205, 14.8.2018, p. 12).’ |
Article 2
The texts of Implementing Regulations (EU) 2018/1129, (EU) 2018/1130 and (EU) 2018/1131 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 6 December 2018, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 5 December 2018.
For the EEA Joint Committee
The President
Oda Helen SLETNES
The Secretaries
To the EEA Joint Committee
Hege M. HOFF
Mikołaj KARŁOWSKI
(1) OJ L 205, 14.8.2018, p. 4.
(2) OJ L 205, 14.8.2018, p. 8.
(3) OJ L 205, 14.8.2018, p. 12.
(*) No constitutional requirements indicated.